High level of heterozygous haplotype of hemoglobin in Abidjan population with mild malaria

BMC Med Genomics. 2022 May 23;15(1):120. doi: 10.1186/s12920-022-01263-3.

Abstract

Background: Sickle cell disease (SCD) is a hemoglobin disorders that concern 300,000 newborns each year around the world. There are hemoglobin haplotypes that affect SCD clinic expression.

Methods: Our goal was to identify the hemoglobin's haplotypes among individuals with mild malaria independently of SCD status in Côte d'Ivoire. To determine these haplotypes, specific restriction enzyme (RE) is used after PCR amplification with each primer. According to the digestion of PCR product by RE, five hemoglobin's haplotypes are found in the world.

Results: In Côte d'Ivoire, no study has yet deeply described the distribution of haplotypes. Four different "classical" haplotypes of hemoglobin were detected: Benin (56.5%), Bantou (28.5%), Senegal (4%), Cameroun (1%); and 10% of atypical profiles. Heterozygous haplotype (69%) were more frequent than homozygous haplotype (31%).

Conclusions: In this preliminary study, we note a high prevalence of atypical and heterozygous haplotype. Benin haplotype that is associated with severity of SCD was most predominant in our studied population.

Keywords: Haplotype; Ivory coast; Malaria; Sickle cell anemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / epidemiology
  • Anemia, Sickle Cell* / genetics
  • Cote d'Ivoire
  • Haplotypes
  • Hemoglobin, Sickle / genetics
  • Hemoglobins
  • Humans
  • Malaria* / complications
  • Malaria* / genetics

Substances

  • Hemoglobin, Sickle
  • Hemoglobins